Ryan Donovan
Physician Assistant, Medical New Haven, CT Physician Assistant
NPI 1881650364 CMS profile 10713364
20 York St, New Haven, CT 06510
General payments
$74,736
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Ryan Donovan of New Haven, CT is reported in the CMS Open Payments database as having received $74,736 across 200 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $30,509 | 65 | |
| 2024 | General | $4,267 | 23 | |
| 2023 | General | $22,636 | 72 | |
| 2022 | General | $11,219 | 21 | |
| 2021 | General | $6,104 | 19 |
Beside peers
- Ryan Donovan
- Physician Assistant, Medical median
- Middle half of Physician Assistant, Medical
- National median
In program year 2025, general payments to Ryan Donovan were reported at $30,509. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.
Show as a table
| Year | Ryan Donovan | Physician Assistant, Medical median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $61 | $19–$193 | $163 |
| 2020 | $0 | $20 | $14–$64 | $114 |
| 2021 | $6,104 | $156 | $41–$563 | $132 |
| 2022 | $11,219 | $185 | $55–$649 | $149 |
| 2023 | $22,636 | $199 | $58–$717 | $160 |
| 2024 | $4,267 | $206 | $62–$740 | $164 |
| 2025 | $30,509 | $214 | $62–$755 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 19 drugsPart D claims
1,349
Drug cost
$691,637
Branded share of claims
45.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 346 | $494,035 | |
| Xarelto Rivaroxaban | Brand | 127 | $169,536 | |
| Dofetilide | Generic | 20 | $6,272 | |
| Flecainide Acetate | Generic | 82 | $4,067 | |
| Metoprolol Succinate | Generic | 243 | $3,713 | |
| Dabigatran Etexilate Dabigatran Etexilate Mesylate | Brand | 11 | $3,414 | |
| Sotalol Sotalol Hcl | Brand | 83 | $2,590 | |
| Amiodarone Hcl | Generic | 94 | $1,866 | |
| Mexiletine Hcl | Generic | 15 | $1,793 | |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | Brand | 45 | $1,533 |
The 10 drugs with the highest cost, of 19 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 21 billing codesPaid by Medicare
$58,426
Medicare patients
752
Services billed
2,027
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Atrial fibrillation | 62% | |
| Arthritis | 51% | |
| Ischemic heart disease | 50% | |
| Heart failure | 49% | |
| Diabetes | 33% | |
| Chronic kidney disease | 33% | |
| Depression | 25% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
200 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Physician Assistant, Medical in Connecticut
Shilpa Desai
Physician Assistant, Medical · Stamford, CT
Gregory Rau
Physician Assistant, Medical · New Haven, CT
John Jasinski
Physician Assistant, Medical · Norwalk, CT
Brianna Paesano
Physician Assistant, Medical · Stamford, CT
Debra Sullivan
Physician Assistant, Medical · Derby, CT
Jonica Pagnucco
Physician Assistant, Medical · Waterbury, CT
Related records
Physician Assistant, Medical in Connecticut
Practitioners in the same specialty and state, ranked by reported value.
All Physician Assistant, Medical
Everyone recorded under this specialty, nationwide.
Doctors in Connecticut
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.